Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review

BACKGROUND: In patients with hormone receptor-positive breast cancer, differentiating between patients with a low and a high risk of recurrence is an ongoing challenge. In current practice, prognostic clinical parameters are used for risk prediction. DNA methylation markers have been proven to be of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res
Autors principals: de Ruijter, Tim C., van der Heide, Frank, Smits, Kim M., Aarts, Maureen J., van Engeland, Manon, Heijnen, Vivianne C. G.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993426/
https://ncbi.nlm.nih.gov/pubmed/32005275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-1250-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars